News and Events
MDReview Now Offering Cardiac Intervention
Press Release – July 2012
‘CINA’ is a new type of peer review to help health care organizations assess the medical necessity of the millions of cardiac interventions performed throughout the United States each year.
Ketchum, ID (date) — MDReview, LLC, the nation’s leading provider of external physician peer review, is now offering a highly sought after service for health care organizations seeking to reduce costs and improve outcomes associated with percutaneous coronary intervention (PCI). The Cardiac Intervention Necessity Assessment (CINA) provides health care organizations a specific, unbiased means to evaluate the medical necessity and appropriateness of PCI procedures performed at their facilities.
Over 1,000,000 PCI procedures are performed every year in the U.S. costing billions of dollars and posing an increased risk of complications and mortality. Led by interventional cardiologist, Robert Duerr, MD FACC, on behalf of MDReview, CINA is an independent, external peer review utilizing well-accepted criteria in clearly establishing the clinical necessity of PCI. CINA can enable health care organizations to confidently offer the safest, highest quality of care for their patients while reducing the occurrence, risk and cost of unnecessary procedures.
“While medical necessity reviews have been performed for some time, MDReview is at the forefront of applying widely-accepted criteria for determining the appropriateness of PCI,” said Dr. Duerr, MDReview’s medical director of cardiac review services. “By using the criteria as an objective foundation for external peer review, MDReview clients achieve solid quality improvement, limit their risk associated with inappropriate care, and reduce patient care costs.”
Specific evidence-based criteria determined by leaders in academic medicine in alignment with the American College of Cardiology Foundation Appropriateness Criteria Task Force’s Appropriateness Criteria for Coronary Revascularization form the foundation of MDReview’s CINA program. Applied within MDReview’s unique and proven peer review process by its carefully selected team of interventional cardiologists, these criteria are used to evaluate each patient’s medical record to determine whether or not the procedure was appropriate.
The results of MDReview’s CINA can be used for the examination of individual or group practice patterns, as well as for the planning and implementation of improvement initiatives and educational programs.
By adding CINA to our extensive peer review portfolio, MDReview will be in a position to expand our supportive role for our rapidly growing client base in every state. We believe this program is integral to our mission of assisting our clients with valuable peer review tools that help improve patient outcomes, manage risk, and reduce costs in an innovative and effective manner.
For more information about MDReview and CINA, contact us at 866-725-1784, or visit md-review.com.
# # #
MDREVIEW PROVIDES HIGHLY EFFECTIVE AND INNOVATIVE PHYSICIAN PEER REVIEW, DELIVERED WITH THE UTMOST INTEGRITY. MDREVIEW’S MAIN PURPOSE IS TO SUPPORT HOSPITALS IN MAKING SOME OF THE MOST IMPORTANT DECISIONS THAT ARE AT THE HEART OF THEIR QUALITY MANAGEMENT EFFORTS. WITH A NATIONAL REACH TO A DIVERSE CLIENT BASE IN ALL 50 STATES, MDREVIEW IS THE STANDARD FOR EXCELLENCE IN PEER REVIEW. MDREVIEW IS LOCATED IN CENTENNIAL, COLORADO. TO LEARN MORE ABOUT MDREVIEW, VISIT WWW.MD-REVIEW.COM.